Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
about
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failureTargeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyCardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.Mechanisms of Autoantibody-Induced Pathology.Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.Cardiomyopathies.PD-1/PD-L pathway and autoimmunity.Conventional apheresis therapies: a review.Apheresis in the treatment of idiopathic dilated cardiomyopathy.Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.The selective therapeutic apheresis procedures.Dilated cardiomyopathy update: infectious-immune theory revisited.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin.Anti beta1-adrenoceptor autoantibodies analyzed in spontaneously beating neonatal rat heart myocyte cultures-comparison of methods.What Are the Newer Applications for Therapeutic Apheresis in Nephrology?: What Is on the Horizon for Therapeutic Apheresis Medicine in Nephrology?Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure.Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.Difficult cases in heart failure: Effective treatment of severe acute myocarditis with intravenous immune globulin and pulse corticosteroids in a 32-year-old patient.
P2860
Q24652847-183E4C38-0CC9-43C6-BA30-D8A58EEDE195Q27000434-813BC43B-1C94-4387-8810-A6DA60AA511DQ33641429-1ABBD268-8EE0-4F59-9B55-3C351B8B19FAQ33740580-724A1986-0400-47EF-BCC2-FB48EF2A3DBCQ33813731-E2956E57-F0BF-4153-9367-F6BB31D8FB33Q34418753-A0F2C86B-7E24-4130-A310-5A98A04FE183Q35492692-E0DA93F7-FA32-46DD-9AD4-BD6DFB1622DAQ35934767-54E5B7FD-2DC6-466F-BAE2-0F94B40CC095Q36287532-7D5007D4-3587-4935-8981-003518335039Q37924701-E333D9F7-5B4A-448B-B557-173529F4797AQ38027456-16C66AD2-AE70-4DD1-9220-C4767FE8A0F1Q38045203-0402A1BB-34AE-452D-B9D0-2206D662AB78Q38066111-D2E2F4E4-2751-4648-87C8-448B4FD4E755Q38082734-09495DA1-4DE1-40BE-9480-8F19B6C7C89EQ38124734-2116D9EE-4F2F-40B9-ADF7-BECA41FEF3DEQ38207936-8CB691BC-5CAB-42B9-B3F7-BB8965FD6922Q38955520-0E974D65-E643-458A-9A78-E63AAB780FF3Q43615988-FA043E51-917D-42E6-AB6C-1794B64DAF0EQ46185078-C67D1698-E456-4359-80B7-068E872AB9B2Q47998095-46C5CF84-6C34-40C0-B8CC-71F494DAED94Q52887237-9CC42CBF-7129-490C-9C3C-F3B7A59FE936Q54294557-C6AE2050-1855-40F4-BBB8-AFF46B18CD34
P2860
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
@en
type
label
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
@en
prefLabel
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
@en
P2093
P1476
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
@en
P2093
Bestvater K
Dörffel WV
Wallukat G
P304
P356
10.1016/0167-5273(96)02598-3
P407
P577
1996-05-01T00:00:00Z